| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $811.2M | +2.8% | +16.0% |
| Cost of Revenue | $199.5M | +2.2% | +14.4% |
| Gross Profit | $611.8M | +3.0% | +16.6% |
| R&D Expense | $191.9M | -0.4% | +11.3% |
| SG&A Expense | $68.5M | -28.5% | -5.4% |
| Operating Income | $240.9M | +22.9% | +32.8% |
| Pre-tax Income | $312.8M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.66B | -14.0% | +58.9% |
| Accounts Receivable | $314.2M | -25.6% | +22.8% |
| Current Assets | $7.11B | +1.7% | +30.6% |
| Total Assets | $8.10B | +1.2% | +25.5% |
| Current Liabilities | $944.9M | -24.7% | +10.3% |
| Total Liabilities |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.31B | — | — |
| Investing Cash Flow | -$936.6M | — | — |
| Financing Cash Flow | $168.7M | — | — |
| +17.9% |
| +29.1% |
| Income Tax | $76.6M | +17.7% | +35.6% |
| Net Income | $236.2M | +17.9% | +27.1% |
| EPS (Basic) | $1.44 | +17.1% | +25.2% |
| EPS (Diluted) | $1.40 | +17.6% | +23.9% |
| $1.06B |
| -22.4% |
| +11.0% |
| Stockholders' Equity | $7.04B | +6.1% | +28.0% |